GE Healthcare Recalls Ventilators Due To Safety Issue

Isn’t it a scary thought to know that a ventilator, something that keeps a person alive after a surgery or traumatic event by breathing for them, could be recalled?

But it’s true, as a new recall has just been announced, and apparently just in the nick of time, as lives are possibly in danger due to the malfunctioning of a popular ventilator.

A Class 1 recall has been issued for GE’s Healthcare Aestiva/5 7900 Ventilator, the U.S. Food & Drug Administration (FDA) just announced. The agency indicated that it notified healthcare professionals of a Class I Recall of the GE Healthcare Aestiva/5 7900 Ventilator.

According to the Safety Alert issued by the FDA, there is a potential for two vaporizers to deliver each agent simultaneously, which could result in over-delivery of a single agent if both vaporizers contain the same agent, or in delivery of more than one agent. Unrecognized overdose with simultaneous inhaled anesthetics can result in hypotension (low blood pressure), arrhythmias (irregular breathing), and bradycardia (low heart rate). Should this occur, persist, and remain unrecognized, circulatory shock might occur. The FDA notes that this ventilator may cause serious adverse health consequences, including death.

The recalled ventilator is intended for continuous breathing support in patients requiring mechanical ventilation during surgical procedures and is used in hospitals and other health care facilities.

The Aestiva/5 7900 ventilator was approved by the U.S. Food and Drug Administration as an anesthesia machine in April 2000.

The Aestiva/5 7900 Ventilator was manufactured on July 2, 2010 and the recall involves products with the following serial numbers: AMRP01031, AMRP00966, AMRP01030, AMRP00968, AMRP00967, AMRP01033, AMRP00970, AMRP00969

On April 10, 2012, the firm sent an “Urgent Medical Device Correction” letter to its customers describing the safety issue, safety instructions, affected product details, product corrections, and contact information, even though the FDA just posted the recall on July 11, 2012.

A Class 1 recall is the agency’s most serious designation indicating that this recall involves a situation in which there exists a reasonable probability that use of the recalled medical device will cause serious adverse health consequences or death.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program which can be accessed at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm.

GE Healthcare, LLC is located at 9900 Innovation Drive, Wauwatosa, Wisconsin, 53226 and may be reached at 1.262.513.4122.



,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Underground Railway Dust May Pose Health Risk

Travelling or working on an underground railway for sustained period of time could have health implications due to concentrations of metal-rich microscopic dust particles.

New Study Helps Understand Why Health Care Costs On The Rise

Although many believe is it medical malpractice suites that are causing the increase in the health care costs, it is actually the fear of them that is partly to blame. Doctors are ordering unnecessary tests and procedures for fear of a patient filing a claim down the road

FDA Issues New Warnings Concerning Tolvaptan

The FDA has issued a drug safety communication concerning Tolvaptan, a selective vasopression V2-receptor antagonist used in heart failure patients to treat clinically significant hypervolemic and euvolemic hyponatremia.

New Antiepileptic Drug Causes Blue Discoloration And Vision Trouble

An antiepileptic drug to hit the market has been known to cause vision troubles and skin discoloration. Almost all patients experienced gray/blue skin discoloration who had been taking the pill for two years. More information is needed to better understand the occurrences.

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

Latest Medical Device Injury News

Women 30% More Likely To Need Repeat Hip Implant Surgery

Doctors traditionally believed the larger the size of the implant, the more protective it was against failure, according to Sedrakyan. However, he said his study found regardless of size, women had a higher rate of revision occurrence, so some other factor besides the actual implants may be leading to this effect.

Transvaginal Mesh Lawsuits – Who Is At Fault?

For some women a pelvic transvaginal mesh product has been a god sent.  To be able to resume a full active life, without the worry of a leaky bladder, is a true miracle for some women.  And, this only became possible with the help of pelvic mesh. The mesh is most commonly used after pelvic [...]

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]